市場調査レポート

商品コード

1771665

医薬品無菌試験市場規模、シェア、動向分析レポート：タイプ別、試験別、製品別、サンプル別、最終用途別、地域別、セグメント別予測、2025年～2033年

Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type, By Test, By Product, By Sample, By End-use, By Region, And Segment Forecasts, 2025 - 2033

出版日: 2025年06月19日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 894,820円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,045,210円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,345,990円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.39円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医薬品無菌性試験市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医薬品無菌性試験市場規模は2033年までに46億4,000万米ドルに達し、2025年から2033年にかけて11.58%のCAGRを記録すると推定されています。

世界の医薬品上市数の増加と政府投資の増加が、世界市場にプラスの影響を与えると予測されています。製薬会社が新薬の数々を市場に投入しているため、厳格な無菌試験プロトコルの需要も並行して急増しています。また、医薬品に対する厳しい規制要件が市場の成長をさらに後押ししています。このように、新薬上市の急増は、医薬品無菌試験市場にかつてない成長機会をもたらしました。

さらに、製薬業界における研究開発活動の重視の高まりは、医薬品無菌試験市場に大きな影響を与えています。製薬会社は革新的かつ先進的な製剤の発見と開発に積極的に関与しているため、これらの製品の安全性と有効性を確保するための堅牢な無菌試験プロトコルの必要性が高まっています。研究開発活動は、新しい医薬品、生物製剤、ワクチンの開発を促進し、規制要件を遵守するための包括的な無菌試験手法が必要となります。

さらに、医薬品承認のための規制機関による厳格な規制により、製薬企業は、これらの進化する基準を満たすために研究開発に多額の投資を行うようになっています。その結果、市場では規制状況に対応するための最先端の試験ソリューションに対する需要が急増しています。例えば、2023年9月、ザルトリウスAGは、無菌試験装置からのサンプリング用のsterisartセプタムを発表しました。これは、二次汚染のリスクを軽減する膜ろ過法に基づく試験用の閉鎖システムです。このようなサービス開始により、市場での競争力が高まりました。

さらに、アンメット・メディカル・ニーズへの対応と革新的な治療法の発見に取り組む製薬業界の姿勢は、堅牢な無菌試験プロトコルの重要性をさらに高めています。新たに上市される医薬品の安全性と有効性を確保するためには、潜在的な汚染物質の検出における正確性と信頼性が最も重要になります。

医薬品無菌試験市場レポートハイライト

タイプ別では、アウトソーシングセグメントが2024年に58.50%の最大売上シェアで市場をリードしました。同分野の成長を牽引しているのは、高品質の無菌試験を実施するインフラを持たない中小規模の製薬・医療機器企業数社にとって魅力的な選択肢として、無菌試験のアウトソーシングに対する要求が高まっていることです。
製品タイプ別では、キット・試薬分野が2024年に最大の売上シェアを占めました。これは、医薬品に生きた微生物が含まれていないことを判定するための標準化された信頼性の高い技術に起因します。
試験タイプ別では、バイオバーデン試験分野が2024年に最大の売上高シェアで市場をリードしました。このセグメントは、厳格な品質管理プロセスや、初期製造から最終流通までのさまざまな製造段階における製品の微生物汚染を定量化する試験の需要によって牽引されています。
サンプル別では、医薬品分野が2024年に最大の収益シェアで市場をリードしました。製品は広く使用されている剤形です。これらの剤形に対する世界の需要の高まりが、このセグメントを牽引する主な要因の一つです。
最終用途別では、医療機器企業が2024年に最大の市場シェアを占めました。無菌試験のような非中核業務をアウトソーシングすることで、医療機器企業は研究開発、製造などのコアコンピタンスに集中することができます。
北米が2024年の売上高シェア52.88%で市場を独占しました。この地域には多数の大手市場企業が存在するため、市場成長に大きく寄与すると予想されます。同地域では、医薬品や医療機器の無菌試験に対する規制要件が厳しく、市場の成長をさらに後押ししています。

地域市場ダッシュボード
世界地域市場のスナップショット
市場規模、予測、動向分析、2021～2033年：
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第10章競合情勢

企業分類
医薬品無菌試験市場シェア分析（2024年）
企業プロファイル
- Pacific Biolabs
- Steris Plc
- Boston Analytical
- Nelson Laboratories, LLC（Sotera Health）
- Sartorius AG
- SOLVIAS AG
- SGS SA
- Labcorp
- Pace Analytical
- Charles River Laboratories
- Thermo Fisher Scientific, Inc.
- Rapid Micro Biosystems
- Almac Group
- Labor LS SE &Co. KG

図表

List of Tables

Table 1 List of abbreviation
Table 2 North America pharmaceutical sterility testing market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 3 North America pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 4 North America pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 5 North America pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 6 North America pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 7 North America pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 8 U.S. pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 9 U.S. pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 10 U.S. pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 11 U.S. pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 12 U.S. pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 13 Canada pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 14 Canada pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 15 Canada pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 16 Canada pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 17 Canada pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 18 Mexico pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 19 Mexico pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 20 Mexico pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 21 Mexico pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 22 Mexico pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 23 Europe pharmaceutical sterility testing market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 24 Europe pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 25 Europe pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 26 Europe pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 27 Europe pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 28 Europe pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 29 UK pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 30 UK pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 31 UK pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 32 UK pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 33 UK pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 34 Germany pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 35 Germany pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 36 Germany pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 37 Germany pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 38 Germany pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 39 France pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 40 France pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 41 France pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 42 France pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 43 France pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 44 Italy pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 45 Italy pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 46 Italy pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 47 Italy pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 48 Italy pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 49 Spain pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 50 Spain pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 51 Spain pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 52 Spain pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 53 Spain pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 54 Norway pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 55 Norway pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 56 Norway pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 57 Norway pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 58 Norway pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 59 Denmark pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 60 Denmark pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 61 Denmark pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 62 Denmark pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 63 Denmark pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 64 Sweden pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 65 Sweden pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 66 Sweden pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 67 Sweden pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 68 Sweden pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 69 Asia Pacific pharmaceutical sterility testing market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 70 Japan pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 71 Japan pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 72 Japan pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 73 Japan pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 74 Japan pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 75 China pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 76 China pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 77 China pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 78 China pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 79 China pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 80 India pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 81 India pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 82 India pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 83 India pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 84 India pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 85 Australia pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 86 Australia pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 87 Australia pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 88 Australia pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 89 Australia pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 90 South Korea pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 91 South Korea pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 92 South Korea pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 93 South Korea pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 94 South Korea pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 95 Thailand pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 96 Thailand pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 97 Thailand pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 98 Thailand pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 99 Thailand pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 100 Latin America pharmaceutical sterility testing market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 101 Latin America pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 102 Latin America pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 103 Latin America pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 104 Latin America pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 105 Latin America pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 106 Brazil pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 107 Brazil pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 108 Brazil pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 109 Brazil pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 110 Brazil pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 111 Argentina pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 112 Argentina pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 113 Argentina pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 114 Argentina pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 115 Argentina pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 116 MEA pharmaceutical sterility testing market estimates and forecasts, by region, 2021 - 2033 (USD Million)
Table 117 MEA pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 118 MEA pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 119 MEA pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 120 MEA pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 121 MEA pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 122 South Africa pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 123 South Africa pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 124 South Africa pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 125 South Africa pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 126 South Africa pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 127 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 128 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 129 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 130 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 131 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 132 Kuwait pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 133 Kuwait pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 134 Kuwait pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 135 Kuwait pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 136 Kuwait pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
Table 137 UAE pharmaceutical sterility testing market estimates and forecasts, by type, 2021 - 2033 (USD Million)
Table 138 UAE pharmaceutical sterility testing market estimates and forecasts, by product, 2021 - 2033 (USD Million)
Table 139 UAE pharmaceutical sterility testing market estimates and forecasts, by test type, 2021 - 2033 (USD Million)
Table 140 UAE pharmaceutical sterility testing market estimates and forecasts, by sample, 2021 - 2033 (USD Million)
Table 141 UAE pharmaceutical sterility testing market estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Pharmaceutical sterility testing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook, 2024 (USD Million)
Fig. 17 Ancillary market outlook, 2024 (USD Million)
Fig. 18 Pharmaceutical sterility testing market dynamics
Fig. 19 Total R&D drug pipeline size, 2021-2024
Fig. 20 Total drug pipeline by development phase, 2024
Fig. 21 Porter's five forces analysis
Fig. 22 PESTEL analysis
Fig. 23 Pharmaceutical sterility testing market type outlook: Segment dashboard
Fig. 24 Pharmaceutical sterility testing market, by type segment: Market share, 2025 & 2033
Fig. 25 Outsourcing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 In-house market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Pharmaceutical sterility testing market product outlook: Segment dashboard
Fig. 28 Pharmaceutical sterility testing market, by product segment: Market share, 2024 & 2033
Fig. 29 Kits and reagents market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Pharmaceutical sterility testing market test type outlook: Segment dashboard
Fig. 33 Pharmaceutical sterility testing market, by test type segment: Market share, 2024 & 2033
Fig. 34 Sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Membrane filtration market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Direct inoculation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Product flush market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Bioburden testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Bacterial endotoxin testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Pharmaceutical sterility testing market sample outlook: Segment dashboard
Fig. 41 Pharmaceutical sterility testing market, by sample segment: Market share, 2024 & 2033
Fig. 42 Pharmaceuticals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Medical devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Biopharmaceuticals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Pharmaceutical sterility testing market end use outlook: Segment dashboard
Fig. 46 Pharmaceutical sterility testing market, by end use segment: Market share, 2024 & 2033
Fig. 47 Compounding pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Medical devices companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Pharmaceutical companies' market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Regional market: Key takeaways
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 North America pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 US pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Canada pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Mexico pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Europe pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 UK pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Germany pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 France pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Italy pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Spain pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Denmark pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Norway pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Sweden pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Asia Pacific pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Japan pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 China pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 India pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Australia pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 South Korea pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Thailand pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 90 Latin America pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Brazil pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Argentina pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 95 MEA pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 South Africa pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Saudi Arabia pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Kuwait pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 UAE pharmaceutical sterility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 104 Market participant categorization
Fig. 105 Heat map analysis

Product Code: GVR-2-68038-425-3

Pharmaceutical Sterility Testing Market Growth & Trends:

The global pharmaceutical sterility testing market size is estimated to reach USD 4.64 billion by 2033, registering a CAGR of 11.58% from 2025 to 2033, according to a new report by Grand View Research, Inc. A growing number of drug launches worldwide, and rising government investments are anticipated to influence the global market positively. As pharmaceutical companies are introducing an array of new drugs to the market, there is a parallel surge in the demand for rigorous sterility testing protocols. Besides, stringent regulatory requirements for pharmaceuticals products further support market growth. Thus, an upsurge in novel drug launches provided unprecedented growth opportunities to the pharmaceutical sterility testing market.

In addition, increasing emphasis on R&D activities in the pharmaceutical industry profoundly impacts the pharmaceutical sterility testing market. As pharmaceutical companies are proactively involved in the discovery and development of innovative & advanced drug formulations, there is a growing need for robust sterility testing protocols to ensure the safety and efficacy of these products. R&D activities drive the development of new pharmaceuticals, biologics, and vaccines, necessitating comprehensive sterility testing methodologies to comply with regulatory requirements.

Furthermore, stringent regulations by regulatory bodies for pharmaceutical product approval prompt pharmaceutical companies to invest significantly in R&D to meet these evolving standards. As a result, the market experiences a surge in demand for state-of-the-art testing solutions to align with the regulatory landscape. For instance, in September 2023, Sartorius AG introduced a sterisart septum for sampling from a sterility testing unit. It is a closed system for testing based on the membrane filtration method that mitigates the risk of secondary contamination. Such service launches offered a competitive edge in the market.

Moreover, the pharmaceutical industry's commitment to addressing unmet medical needs and discovering innovative therapeutic avenues further amplifies the importance of robust sterility testing protocols. The need for accuracy & reliability in detecting any potential contaminants becomes paramount to ensure the safety and efficacy of these newly launched drugs.

Pharmaceutical Sterility Testing Market Report Highlights:

Based on type, the outsourcing segment led the market with the largest revenue share of 58.50% in 2024. The segment growth is driven by increasing requirements for Outsourcing sterility testing as attractive alternative for several small- & medium-sized pharmaceutical and medical device companies, which may lack the infrastructure to conduct quality sterility testing
Based on product type, the kits and reagents segment held the market with the largest revenue share in 2024, attributing to a standardized and reliable techniques to determine the absence of live microorganisms in pharmaceutical products
Based on test type, the bioburden testing segment led the market with the largest revenue share in 2024. The segment is driven by strict quality control processes and the demand for testing to quantify microbial contamination of a product at different stages of production from initial manufacturing to final distribution
Based on sample, the pharmaceuticals segment led the market with the largest revenue share in 2024. The products are widely used dosage forms. The growing demand or these dosage forms globally is one of the major factors driving this segment
Based on end-use, the medical device companies held the largest market share in 2024. By outsourcing noncore activities like sterility testing, medical device companies can concentrate on their core competencies, such as research, development, and manufacturing.
North America dominated the market with a revenue share of 52.88% in 2024. The presence of a large number of major market players in this region is expected to contribute to the market growth significantly. Stringent regulatory requirements for sterility testing of pharmaceuticals and medical devices in this region further supports market growth.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Value chain based analysis (Model 2)
- 1.7.3. Multivariate Analysis (Model 3)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Pharmaceutical Sterility Testing Market: Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
3.2. Pharmaceutical Sterility Testing Market Dynamics
- 3.2.1. Market Driver Impact Analysis
  - 3.2.1.1. Supportive Government Investment in the Healthcare Industry
  - 3.2.1.2. Increasing R&D Activities
  - 3.2.1.3. Increasing Number of Drug Launches
  - 3.2.1.4. Increasing Focus on Quality and Sterility
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Compliance Issues While Outsourcing
  - 3.2.2.2. Third Party Performance
3.3. Technological Landscape
3.4. Pricing Model Analysis
3.5. Pharmaceutical Sterility Testing Market: Analysis Tools
- 3.5.1. Porter's Five Forces Analysis
- 3.5.2. PESTEL Analysis

Chapter 4. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Pharmaceutical Sterility Testing Market Movement Analysis
4.3. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. In-House
- 4.4.1. In-house Market Estimates and Forecasts, 2021 - 2033 (USD million)
4.5. Outsourcing
- 4.5.1. Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Sterility Testing Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Pharmaceutical Sterility Testing Market Movement Analysis
5.3. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Kits and Reagents
- 5.4.1. Kits and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Instruments
- 5.5.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Services
- 5.6.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Pharmaceutical Sterility Testing Market Movement Analysis
6.3. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Million)
6.4. Sterility Testing
- 6.4.1. Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.1.1. Membrane Filtration
    - 6.4.1.1.1. Membrane Filtration Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.1.2. Direct Inoculation
    - 6.4.1.2.1. Direct Inoculation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 6.4.1.3. Product Flush
    - 6.4.1.3.1. Product Flush Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Bioburden Testing
6.6. Bacterial Endotoxin Testing

Chapter 7. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Pharmaceutical Sterility Testing Market Movement Analysis
7.3. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Sample, 2021 to 2033 (USD Million)
- 7.3.1. Pharmaceuticals
  - 7.3.1.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Medical Devices
  - 7.3.2.1. Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Biopharmaceuticals
  - 7.3.3.1. Biopharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Pharmaceutical Sterility Testing Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Global Pharmaceutical Sterility Testing Market Movement Analysis
8.3. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Compounding Pharmacies
- 8.4.1. Compounding Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Medical Device Companies
- 8.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Pharmaceutical Companies
- 8.6.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Others
- 8.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Pharmaceutical Sterility Testing Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

9.1. Regional Market Dashboard
9.2. Global Regional Market Snapshot
9.3. Market Size, & Forecasts, Trend Analysis, 2021 to 2033:
9.4. North America
- 9.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Europe
- 9.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Denmark
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.8. Sweden
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Competitive Scenario
  - 9.5.8.3. Regulatory Framework
  - 9.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.9. Norway
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Competitive Scenario
  - 9.5.9.3. Regulatory Framework
  - 9.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Asia Pacific
- 9.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Competitive Scenario
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.5. Australia
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Competitive Scenario
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.6. South Korea
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Competitive Scenario
  - 9.6.6.3. Regulatory Framework
  - 9.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Competitive Scenario
  - 9.6.7.3. Regulatory Framework
  - 9.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Latin America
- 9.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.8. MEA
- 9.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Competitive Scenario
  - 9.8.2.3. Regulatory Framework
  - 9.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Competitive Scenario
  - 9.8.3.3. Regulatory Framework
  - 9.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Competitive Scenario
  - 9.8.4.3. Regulatory Framework
  - 9.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Competitive Scenario
  - 9.8.5.3. Regulatory Framework
  - 9.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Pharmaceutical Sterility Testing Market Share Analysis, 2024
10.3. Company Profiles
- 10.3.1. Pacific Biolabs
  - 10.3.1.1. Company overview
  - 10.3.1.2. Financial performance
  - 10.3.1.3. Product benchmarking
  - 10.3.1.4. Strategic initiatives
- 10.3.2. Steris Plc
  - 10.3.2.1. Company overview
  - 10.3.2.2. Financial performance
  - 10.3.2.3. Product benchmarking
  - 10.3.2.4. Strategic initiatives
- 10.3.3. Boston Analytical
  - 10.3.3.1. Company overview
  - 10.3.3.2. Financial performance
  - 10.3.3.3. Product benchmarking
  - 10.3.3.4. Strategic initiatives
- 10.3.4. Nelson Laboratories, LLC (Sotera Health)
  - 10.3.4.1. Company overview
  - 10.3.4.2. Financial performance
  - 10.3.4.3. Product benchmarking
  - 10.3.4.4. Strategic initiatives
- 10.3.5. Sartorius AG
  - 10.3.5.1. Company overview
  - 10.3.5.2. Financial performance
  - 10.3.5.3. Product benchmarking
  - 10.3.5.4. Strategic initiatives
- 10.3.6. SOLVIAS AG
  - 10.3.6.1. Company overview
  - 10.3.6.2. Financial performance
  - 10.3.6.3. Product benchmarking
  - 10.3.6.4. Strategic initiatives
- 10.3.7. SGS SA
  - 10.3.7.1. Company overview
  - 10.3.7.2. Financial performance
  - 10.3.7.3. Product benchmarking
  - 10.3.7.4. Strategic initiatives
- 10.3.8. Labcorp
  - 10.3.8.1. Company overview
  - 10.3.8.2. Financial performance
  - 10.3.8.3. Product benchmarking
  - 10.3.8.4. Strategic initiatives
- 10.3.9. Pace Analytical
  - 10.3.9.1. Company overview
  - 10.3.9.2. Financial performance
  - 10.3.9.3. Product benchmarking
  - 10.3.9.4. Strategic initiatives
- 10.3.10. Charles River Laboratories
  - 10.3.10.1. Company overview
  - 10.3.10.2. Financial performance
  - 10.3.10.3. Product benchmarking
  - 10.3.10.4. Strategic initiatives
- 10.3.11. Thermo Fisher Scientific, Inc.
  - 10.3.11.1. Company overview
  - 10.3.11.2. Financial performance
  - 10.3.11.3. Product benchmarking
  - 10.3.11.4. Strategic initiatives
- 10.3.12. Rapid Micro Biosystems
  - 10.3.12.1. Company overview
  - 10.3.12.2. Financial performance
  - 10.3.12.3. Product benchmarking
  - 10.3.12.4. Strategic initiatives
- 10.3.13. Almac Group
  - 10.3.13.1. Company overview
  - 10.3.13.2. Financial performance
  - 10.3.13.3. Product benchmarking
  - 10.3.13.4. Strategic initiatives
- 10.3.14. Labor LS SE & Co. KG
  - 10.3.14.1. Company overview
  - 10.3.14.2. Financial performance
  - 10.3.14.3. Product benchmarking
  - 10.3.14.4. Strategic initiatives

医薬品無菌試験市場規模、シェア、動向分析レポート：タイプ別、試験別、製品別、サンプル別、最終用途別、地域別、セグメント別予測、2025年～2033年

Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type, By Test, By Product, By Sample, By End-use, By Region, And Segment Forecasts, 2025 - 2033

医薬品無菌性試験市場の成長と動向：

医薬品無菌試験市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章医薬品無菌試験市場：変数、動向、範囲

第4章医薬品無菌試験市場：タイプ推定・動向分析

第5章医薬品無菌試験市場：製品推定・動向分析

第6章医薬品無菌試験市場：試験タイプの推定・動向分析

第7章医薬品無菌試験市場：サンプル推定・動向分析

第8章医薬品無菌試験市場：最終用途の推定・動向分析

第9章医薬品無菌試験市場：タイプ、製品、試験、サンプル、最終用途別の地域推定・動向分析

第10章競合情勢

List of Tables

List of Figures

Pharmaceutical Sterility Testing Market Growth & Trends:

Pharmaceutical Sterility Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Pharmaceutical Sterility Testing Market: Variables, Trends, & Scope

Chapter 4. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

Chapter 5. Pharmaceutical Sterility Testing Market: Product Estimates & Trend Analysis

Chapter 6. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

Chapter 7. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

Chapter 8. Pharmaceutical Sterility Testing Market: End Use Estimates & Trend Analysis

Chapter 9. Pharmaceutical Sterility Testing Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

Chapter 10. Competitive Landscape

医薬品無菌試験市場規模、シェア、動向分析レポート：タイプ別、試験別、製品別、サンプル別、最終用途別、地域別、セグメント別予測、2025年～2033年

Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type, By Test, By Product, By Sample, By End-use, By Region, And Segment Forecasts, 2025 - 2033

医薬品無菌性試験市場の成長と動向：

医薬品無菌試験市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品無菌試験市場：変数、動向、範囲

第4章 医薬品無菌試験市場：タイプ推定・動向分析

第5章 医薬品無菌試験市場：製品推定・動向分析

第6章 医薬品無菌試験市場：試験タイプの推定・動向分析

第7章 医薬品無菌試験市場：サンプル推定・動向分析

第8章 医薬品無菌試験市場：最終用途の推定・動向分析

第9章 医薬品無菌試験市場：タイプ、製品、試験、サンプル、最終用途別の地域推定・動向分析

第10章 競合情勢

List of Tables

List of Figures

Pharmaceutical Sterility Testing Market Growth & Trends:

Pharmaceutical Sterility Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Pharmaceutical Sterility Testing Market: Variables, Trends, & Scope

Chapter 4. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

Chapter 5. Pharmaceutical Sterility Testing Market: Product Estimates & Trend Analysis

Chapter 6. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

Chapter 7. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

Chapter 8. Pharmaceutical Sterility Testing Market: End Use Estimates & Trend Analysis

Chapter 9. Pharmaceutical Sterility Testing Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

Chapter 10. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章医薬品無菌試験市場：変数、動向、範囲

第4章医薬品無菌試験市場：タイプ推定・動向分析

第5章医薬品無菌試験市場：製品推定・動向分析

第6章医薬品無菌試験市場：試験タイプの推定・動向分析

第7章医薬品無菌試験市場：サンプル推定・動向分析

第8章医薬品無菌試験市場：最終用途の推定・動向分析

第9章医薬品無菌試験市場：タイプ、製品、試験、サンプル、最終用途別の地域推定・動向分析

第10章競合情勢